Parental reports of adverse events following simultaneously given dT-IPV and MMR vaccines in healthy 9-year-old children

European Journal of Pediatrics

Volumn 170, Issue 3, 2011, Pages 339-345

  Kemmeren, Jeanet M ^a   Van Der Maas, Nicoline A T ^a   De Melker, Hester E ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Adverse events; dT IPV vaccine; MMR vaccine; Parental reports

Indexed keywords

ANALGESIC AGENT; DIPHTHERIA POLIOMYELITIS TETANUS VACCINE; MEASLES MUMPS RUBELLA VACCINE;

ARTICLE; CHILD; COLD CLAMMY SKIN; DIPHTHERIA; DIZZINESS; DRUG INDUCED HEADACHE; FEMALE; FEVER; HUMAN; INFANT; INFECTION PREVENTION; INJECTION SITE PAIN; INJECTION SITE SWELLING; MAJOR CLINICAL STUDY; MALE; MEASLES; MUMPS; NAUSEA; NETHERLANDS; PALLOR; POLIOMYELITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RUBELLA; SCHOOL CHILD; SKIN REDNESS; STRUCTURED QUESTIONNAIRE; SYNCOPE; TETANUS; TREATMENT RESPONSE; VOMITING;

CHILD; DIPHTHERIA-TETANUS VACCINE; HUMANS; MEASLES-MUMPS-RUBELLA VACCINE; PARENTS; POLIOVIRUS VACCINE, INACTIVATED; QUESTIONNAIRES; VACCINES, COMBINED;

EID: 79954443216     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-010-1294-4     Document Type: Article

References (38)

1. LK Ammari LM Bell RL Hodinka 1993 Secondary measles vaccine failure in healthcare workers exposed to infected patients Infect Control Hosp Epidemiol 14 81 86 8440884 1:STN:280:DyaK3s7nvFOhsA%3D%3D 10.1086/646687
2. FE Andre 1999 Development and clinical application of new polyvalent combined paediatric vaccines Vaccine 17 1620 16276 10194814 1:STN:280: DyaK1M3htVOiug%3D%3D 10.1016/S0264-410X(98)00426-5 (Pubitemid 29138892)
3. NW Baylor W Egan P Richman 2002 Aluminum salts in vaccines-US perspective Vaccine 20 Suppl 3 S18 S23 12184360 1:CAS:528:DC%2BD38XksVamsbw%3D 10.1016/S0264-410X(02)00166-4 (Pubitemid 34607671)
4. PC Begue EM Grimprel MD Giovannangeli VI Abitbol 1998 Comparative reactogenicity and immunogenicity of booster doses of diphtheria-tetanus- acellular pertussis-inactivated poliovirus vaccine and diphtheria-tetanus- inactivated poliovirus vaccine in preadolescents Pediatr Infect Dis J 17 804 809 9779766 1:STN:280:DyaK1cvltFSntA%3D%3D 10.1097/00006454-199809000-00011 (Pubitemid 28475549)
5. C Black JA Kaye H Jick 2003 MMR vaccine and idiopathic thrombocytopaenic purpura Br J Clin Pharmacol 55 107 111 12534647 10.1046/j.1365-2125.2003.01790.x (Pubitemid 36110846)
6. S Black LR Friedland A Schuind B Howe 2006 Immunogenicity and safety of a combined DTaP-IPV vaccine compared with separate DTaP and IPV vaccines when administered as pre-school booster doses with a second dose of MMR vaccine to healthy children aged 4-6 years Vaccine 24 6163 6171 16759769 1:CAS:528:DC%2BD28XotV2ntbY%3D 10.1016/j.vaccine.2006.04.001 (Pubitemid 44175612)
7. H Bogaerts 2003 The future of childhood immunizations: examining the European experience Am J Manag Care 9 S30 S36 12564787
8. L Brabin SA Roberts R Stretch, et al. 2008 Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study BMJ 336 1056 1058 18436917 10.1136/bmj.39541.534109.BE (Pubitemid 351692248)
9. M Bults JM Kemmeren NA van der Maas 2007 Adverse events following booster doses of diphtheria-tetanus-inactivated poliovirus and acellular pertussis vaccines for 4-year-old children in The Netherlands Vaccine 25 5272 5277 17573165 1:STN:280:DC%2BD2szosFWhtw%3D%3D 10.1016/j.vaccine.2007.05.017 (Pubitemid 46992761)
10. RT Chen GM Goldbaum SG Wassilak, et al. 1989 An explosive point-source measles outbreak in a highly vaccinated population. Modes of transmission and risk factors for disease Am J Epidemiol 129 173 182 2910058 1:STN:280: DyaL1M%2Fos1ertw%3D%3D (Pubitemid 19030710)
11. CJ Clements E Griffiths 2002 The global impact of vaccines containing aluminium adjuvants Vaccine 20 Suppl 3 S24 S33 12184361 10.1016/S0264-410X(02) 00168-8
12. Cochi S, Wharton M, Plotkin S (1994) Mumps vaccine. In: Plotkin SA, Mortimer EAJ (eds) Vaccines. WB Saunders, Philadelphia, pp 277-301
13. RL Davis E Marcuse S Black, et al. 1997 MMR2 immunisation at 4 to 5 years and 10 to 12 years of age: a comparison of adverse clinical events after immunisation in the Vaccine Safety Datalink Project Pediatrics 100 767 771 9346975 1:STN:280:DyaK1c%2FhtVKluw%3D%3D 10.1542/peds.100.5.767 (Pubitemid 27463311)
14. D Dodd 2003 Benefits of combination vaccines: effective vaccination on a simplified schedule Am J Manag Care 9 S6 S12 12564784
15. MS Gold S Noonan M Osbourn, et al. 2003 Local reactions after the fourth dose of acellular pertussis vaccine in South Australia Med J Aust 179 191 194 12914508 (Pubitemid 37038201)
16. L Gothefors E Bergstrom M Backman 2001 Immunogenicity and reactogenicity of a new measles, mumps and rubella vaccine when administered as a second dose at 12 years of age Scand J Infect Dis 33 545 549 11515768 1:CAS:528: DC%2BD3MXmsVOksLc%3D 10.1080/00365540110026593 (Pubitemid 32755350)
17. DA Gust S Campbell A Kennedy, et al. 2006 Parental concerns and medical-seeking behavior after immunization Am J Prev Med 31 32 35 16777540 10.1016/j.amepre.2006.03.017 (Pubitemid 43956602)
18. L Gustaffson HO Hallander P Olin, et al. 1996 A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine N Engl J Med 334 3 49 355
19. SA Halperin D Scheifele E Mills, et al. 2003 Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccine Vaccine 21 2298 2306 12744860 1:CAS:528:DC%2BD3sXjs1Wmur4%3D 10.1016/S0264-410X(03)00173-7 (Pubitemid 36561321)
20. LM Huang LY Chang H Tang, et al. 2005 Immunigenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine in healthy Taiwanese children and adolescents J Adolesc Health 37 517 16310132 10.1016/j.jadohealth.2005.08.009 (Pubitemid 41681774)
21. T Jefferson M Rudin C Di Pietrantonj 2004 Adverse events after immunisation with aluminium-containing DTP vaccines: systematic review of the evidence Lancet Infect Dis 4 84 90 14871632 1:CAS:528:DC%2BD2cXhvVCjurw%3D 10.1016/S1473-3099(04)00927-2 (Pubitemid 38169274)
22. CW LeBaron BI Daoling BJ Sullivan, et al. 2006 Evaluation of potentially common adverse events associated with the first and second doses of measles-mumps-rubella vaccine Pediatrics 118 1422 1430 17015532 10.1542/peds.2006-0678 (Pubitemid 46393787)
23. Maas van der NAT, Zonnenberg-Hoff IF, David S, et al (2008) Adverse events following immunisation under the national vaccination programme of The Netherlands. Number XIV-Reports in 2007. National Institute for Public Health and Environment, Bilthoven
24. Markowitz L, Katz S (1994) Measles vaccine. In: Plotkin SA, Mortimer EAJ (eds) Vaccines. WB Saunders, Philadelphia, pp 229-276
25. H Marshall T Nolan D Roberton, et al. 2006 A comparison of booster immunisation with a combination DTPa-IPV vaccine or DTPa plus IPV in separate injections when co-administered with MMR, at age 4-6 years Vaccine 24 6120 6128 16822597 1:CAS:528:DC%2BD28XotV2ntbo%3D 10.1016/j.vaccine.2006.05.017 (Pubitemid 44175615)
26. de Melker H, Gerritsen A, Hahné S (2007) The national immunisation programme in the Netherlands. RIVM, Bilthoven
27. E Miller P Waight H Laurichesse, et al. 2001 Immunogenicity and reactogenicity of acellular diphtheria/tetanus/pertussis vaccines given as a pre-school booster: effect of simultaneous administration of MMR Vaccine 19 3904 3911 11427264 1:CAS:528:DC%2BD3MXks1Oisr0%3D 10.1016/S0264-410X(01)00123-2 (Pubitemid 32566313)
28. P Olin F Rasmussen L Gustaffson, et al. 1997 Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compard with whole-cell pertussis vaccine Lancet 350 1569 1577 9393335 1:STN:280:DyaK1c%2FlsFSmsQ%3D%3D 10.1016/S0140-6736(97)06508-2 (Pubitemid 28036599)
29. PA Parment A Svahn U Ruden, et al. 2003 Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age Scand J Infect Dis 35 736 742 14606613 1:CAS:528:DC%2BD3sXosVGiu7g%3D 10.1080/00365540310015719 (Pubitemid 37336901)
30. H Peltola OP Heinonen 1986 Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins Lancet 1 939 942 2871241 1:STN:280:DyaL283gt1Wksg%3D%3D 10.1016/S0140-6736(86) 91044-5 (Pubitemid 16143073)
31. MB Rennels 2002 Combination vaccines Pediatr Infect Dis J 21 255 257 12005092 10.1097/00006454-200203000-00018 (Pubitemid 34214145)
32. MB Rennels 2003 Extensive swelling reactions occurring after booster doses of diphtheria-tetanus-acellular pertussis vaccines Semin Pediatr Infect Dis 14 196 198 12913831 10.1016/S1045-1870(03)00033-5 (Pubitemid 36994971)
33. R Sanger U Behre KH Krause, et al. 2007 Booster vaccination and 1-year follow-up of 4-8 year old children with a reduced-antigen-content dTpa-IPV vaccine Eur J Pediatr 166 1229 1236 17235521 10.1007/s00431-006-0403-x (Pubitemid 350029473)
34. DW Scheifele SA Halperin AC Ferguson 2001 Assessment of injection site reactions to an acellular pertussis-based combination vaccine, including novel use of skin tests with vaccine antigens Vaccine 19 4720 4726 11535322 1:CAS:528:DC%2BD3MXmsFWrt7c%3D 10.1016/S0264-410X(01)00230-4 (Pubitemid 32800756)
35. DW Scheifele SA Halperin JJ Ochnio, et al. 2005 A modified vaccine reduces the rate of large injection site reactions to the preschool booster dose of diphtheria-tetanus-acellular pertussis vaccine: results of a randomized, controlled trial Pediatr Infect Dis J 24 1059 1066 16371866 10.1097/01.inf. 0000190028.96152.46 (Pubitemid 43011060)
36. M Virtanen H Peltola M Paunio OP Heinonen 2000 Day-to-day reactogenicity and the healthy vaccinee effect of measles-mumps-rubella vaccination Pediatrics 106 e62 11061799 1:STN:280:DC%2BD3M%2FlvVKnsA%3D%3D 10.1542/peds.106.5.e62
37. F Wei JP Mullooly M Goodman, et al. 2009 Identification and characteristics of vaccine refusers BMC Pediatr 5 18 10.1186/1471-2431-9-18
38. F Zhu S Zhan Q Hou, et al. 2010 Booster vaccination against pertussis in Chinese children at 6 years of age using reduced antigen content diphteria-tetanus-acellular pertussis vaccine (BoostrixTM) Hum Vaccin 6 263 269 1:CAS:528:DC%2BC3cXht1ertbfL 10.4161/hv.6.3.10503